MEDICINE AND

One of the most common melanoma-related CDKN2A mutations reported in North America is the V126D mutation. We examined nine markers surrounding CDKN2A in three American and four Canadian families carrying the V126D mutation. All seven families had a haplotype consistent with a common ancestor/founder for this mutation. In addition, the mutation appears to have originated 34–52 generations ago (1-LOD-unit support interval 13–98 generations). © 2001 Cancer Research Campaign http://www.bjcancer.com

[1]  Å. Borg,et al.  Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families , 2001, Genes, chromosomes & cancer.

[2]  J. Struewing,et al.  A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families. , 2000, American journal of human genetics.

[3]  J. Struewing,et al.  Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. , 2000, Journal of the National Cancer Institute.

[4]  P. Bruzzi,et al.  Characterization of ligurian melanoma families and risk of occurrence of other neoplasia , 1999, International journal of cancer.

[5]  M. Tucker,et al.  Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  X. Estivill,et al.  CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia , 1999, Journal of medical genetics.

[7]  D. Bishop,et al.  Mutation testing in melanoma families: INK4A, CDK4 and INK4D , 1999, British Journal of Cancer.

[8]  L. Chin,et al.  Malignant melanoma: modern black plague and genetic black box. , 1998, Genes & development.

[9]  R. MacKie,et al.  CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas. , 1998, The Journal of investigative dermatology.

[10]  M. King,et al.  Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. , 1998, American journal of human genetics.

[11]  Ken Chen,et al.  The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.

[12]  Yue Xiong,et al.  ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.

[13]  D. Stoppa-Lyonnet,et al.  Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. , 1998, Human molecular genetics.

[14]  G. Peters,et al.  Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma , 1996, Molecular and cellular biology.

[15]  Å. Borg,et al.  Novel germline p16 mutation in familial malignant melanoma in southern Sweden. , 1996, Cancer research.

[16]  L. Sandkuijl,et al.  Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.

[17]  H. Varmus,et al.  Mutations associated with familial melanoma impair p16INK4 function , 1995, Nature Genetics.

[18]  R. DePinho,et al.  Inhibition of ras-induced proliferation and cellular transformation by p16INK4 , 1995, Science.

[19]  W. Clark,et al.  Germline p16 mutations in familial melanoma , 1994, Nature Genetics.

[20]  G. Hannon,et al.  A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.

[21]  D. Bishop,et al.  A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family. , 2001, Human molecular genetics.

[22]  David Hogg,et al.  Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma , 1999, Nature Genetics.

[23]  P. Pollock,et al.  Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: Evidence for common founders and independent mutations , 1998, Human mutation.

[24]  M. King,et al.  Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. , 1996, American journal of human genetics.

[25]  M. Tucker,et al.  Familial melanoma and its management , 1996 .